BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3379412)

  • 21. Co-localization and characterization of immunoreactive peptides derived from two opioid precursors in guinea pig adrenal glands.
    Evans CJ; Erdelyi E; Hunter J; Barchas JD
    J Neurosci; 1985 Dec; 5(12):3423-7. PubMed ID: 3908623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional distribution of methionine-enkephalin-Arg6-Phe7 in the rat brain: comparative study with the distribution of other opioid peptides.
    Giraud P; Castanas E; Patey G; Oliver C; Rossier J
    J Neurochem; 1983 Jul; 41(1):154-60. PubMed ID: 6688089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
    Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
    Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in opioid receptor selectivity following processing of peptide E: effect on gut motility.
    Davis TP; Gillespie TJ; Shook J; Kramer TH; Hoyer G; Hawkins K; Davis P; Yamamura HI; Burks TF
    Gastroenterology; 1991 Jun; 100(6):1603-15. PubMed ID: 1850373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid peptides derived from pre-proenkephalin B sequence: biological evaluation in guinea pig ileum and mouse vas deferens.
    Sánchez-Blázquez P; Garzón J; Lee NM
    Proc West Pharmacol Soc; 1983; 26():85-8. PubMed ID: 6688470
    [No Abstract]   [Full Text] [Related]  

  • 27. Modulation of peristalsis in the guinea-pig isolated small intestine by exogenous and endogenous opioids.
    Waterman SA; Costa M; Tonini M
    Br J Pharmacol; 1992 Aug; 106(4):1004-10. PubMed ID: 1356564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro pharmacology of the opioid peptides, enkephalins and endorphins.
    Waterfield AA; Smokcum RW; Hughes J; Kosterlitz HW; Henderson G
    Eur J Pharmacol; 1977 May; 43(2):107-16. PubMed ID: 17538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid activity of enkephalin analogues containing the kyotorphin-related structure in the N-terminus.
    Amano H; Morimoto Y; Kaneko S; Takagi H
    Neuropharmacology; 1984 Apr; 23(4):395-400. PubMed ID: 6328351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.
    Kamikawa Y; Shimo Y
    Br J Pharmacol; 1983 Apr; 78(4):693-9. PubMed ID: 6303485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opioid receptor selectivity of dynorphin gene products.
    James IF; Fischli W; Goldstein A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):88-93. PubMed ID: 6141278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enkephalins in the rat pituitary gland: immunohistochemical and biochemical observations.
    Panula P; Lindberg I
    Endocrinology; 1987 Jul; 121(1):48-58. PubMed ID: 2954813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for lack of modulation of mu-opioid agonist action by delta-opioid agonists in the mouse vas deferens and guinea-pig ileum.
    Elliott J; Traynor JR
    Br J Pharmacol; 1995 Mar; 114(5):1064-8. PubMed ID: 7780641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of mechanisms and sites of actions of mu and delta opioid receptor activation in the canine intestine.
    Fox-Threlkeld JE; Daniel EE; Christinck F; Hruby VJ; Cipris S; Woskowska Z
    J Pharmacol Exp Ther; 1994 Feb; 268(2):689-700. PubMed ID: 8113980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
    Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
    Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that the agonist action of dynorphin A(1-8) in the guinea-pig myenteric-plexus may be mediated partly through conversion to [Leu5]enkephalin.
    Dixon DM; Traynor JR
    Br J Pharmacol; 1990 Nov; 101(3):674-8. PubMed ID: 1981690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
    Dray A; Nunan L; Wire W
    J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands.
    Kramer TH; Davis P; Hruby VJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1993 Aug; 266(2):577-84. PubMed ID: 8394911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative immunohistochemical demonstration of peptide F- and other enkephalin-containing neurons in the enteric nervous system of the rat.
    Wang YN; Wyatt RJ
    Synapse; 1987; 1(2):208-13. PubMed ID: 3333199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proenkephalin A derivatives in lacrimal gland: occurrence and regulation of lacrimal function.
    Cripps MM; Bennett DJ
    Exp Eye Res; 1992 Jun; 54(6):829-34. PubMed ID: 1521577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.